1996
DOI: 10.1172/jci118391
|View full text |Cite
|
Sign up to set email alerts
|

Maternal vasoactive intestinal peptide and the regulation of embryonic growth in the rodent.

Abstract: Vasoactive intestinal peptide (VIP) has been shown to regulate early postimplantation growth in rodents through central nervous system receptors. However, the source of VIP mediating these effects is unknown. Although VIP binding sites are present prenatally, VIP mRNA was not detected in the rat central nervous system before birth and was detected in the periphery only during the last third of pregnancy. In the present study, the embryonic day (E11) rat embryo/trophoblast was shown to have four times the VIP c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
54
0
1

Year Published

1997
1997
2016
2016

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 65 publications
(60 citation statements)
references
References 31 publications
(51 reference statements)
5
54
0
1
Order By: Relevance
“…VIP has previously been shown to be a maternal factor acting on early brain development in rodents (80). Similarly, some data also suggest that maternal VIP could act on the embryonic and fetal brain in humans (41).…”
Section: Figure 10mentioning
confidence: 91%
“…VIP has previously been shown to be a maternal factor acting on early brain development in rodents (80). Similarly, some data also suggest that maternal VIP could act on the embryonic and fetal brain in humans (41).…”
Section: Figure 10mentioning
confidence: 91%
“…65 It is now known that VIP levels rise at the fetal-maternal interface at early gestation peaking at placentation begin. 66 Its role in embryogenesis was revealed after observing that its blockade during midgestation ends in induced growth retardation and microcephaly. 66 This is further confirmed in VIP À/À fetuses that highlights the role of maternal VIP for early neural development.…”
Section: Modulators Of the Immune Responses During Pregnancymentioning
confidence: 99%
“…The source of VIP may be extrapancreatic embryonic tissues that express VIP mRNA during embryonic life (41). Maternal tissue may be another source of VIP acting on VIP binding sites in the embryo: VIP levels are high in maternal blood, and VIP can be transported from the maternal blood to the embryo (42). …”
Section: Discussionmentioning
confidence: 99%